marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Blueprint Medicines Corporation Cash Flow 2011-2024 | BPMC
Annual Cash Flow Blueprint Medicines Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-437 M | -502 M | -299 M | 387 M | -278 M | -175 M | -120 M | -24.5 M | -31.7 M | - | - | - | - |
Depreciation & Amortization |
11.7 M | 11.7 M | 6.48 M | 6.56 M | 5.26 M | 4.25 M | 1.58 M | 1.58 M | 948 K | 622 K | 501 K | - | - |
Accounts Payables |
4.71 M | 2.73 M | 8.33 M | 4.37 M | 4.79 M | 3.3 M | 3.74 M | 2.21 M | 2.46 M | - | - | - | - |
Accounts Receivables |
42.8 M | 23.5 M | 25.2 M | 7.1 M | 663 K | - | - | - | - | - | - | - | - |
Total Inventories |
21.2 M | 29.7 M | 21.8 M | 8.58 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Blueprint Medicines Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -102 M | - | - | - | -123 M | - | -381 M | - | -133 M | - | -285 M | - | -126 M | - | 412 M | -210 M | -109 M | - | -233 M | -161 M | -80.2 M | - | -107 M | -52.4 M | -49.6 M | - | -85.1 M | -58.6 M | -31.1 M | - | -5.72 M | 12.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 4.81 M | - | - | - | 3.68 M | - | 4.72 M | - | 1.63 M | - | 4.82 M | 1.6 M | 1.61 M | - | 4.89 M | 3.24 M | 1.57 M | - | 3.68 M | 2.39 M | 1.18 M | - | 3.08 M | 1.91 M | 780 K | - | 1.19 M | 791 K | 398 K | - | 1.19 M | 782 K | 386 K | - | 615 K | 411 K | 209 K | - | 416 K | 273 K | 134 K | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
4.72 M | 4.86 M | 4.93 M | 4.71 M | 6.96 M | 6.98 M | 10.6 M | 2.73 M | 4.23 M | - | 18 M | 8.33 M | 9.55 M | 1.85 M | 2.89 M | 4.37 M | 4.37 M | 4.37 M | 4.37 M | 4.79 M | 4.79 M | 4.79 M | 4.79 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.74 M | 3.74 M | 3.74 M | 3.74 M | 2.21 M | 2.21 M | 2.21 M | 2.21 M | 2.46 M | 2.46 M | 2.46 M | 2.46 M | 814 K | 814 K | 814 K | 814 K | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
65.8 M | 85.1 M | 60 M | 42.8 M | 40.9 M | 35.1 M | 30 M | 23.5 M | 19.3 M | - | 28.8 M | 25.2 M | 18.4 M | 25.5 M | 34.7 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 663 K | 663 K | 663 K | 663 K | 64 K | 64 K | 64 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
12.5 M | 14.8 M | 30.9 M | 21.2 M | 16.5 M | 17 M | 17.5 M | 29.7 M | 35.3 M | - | 30.1 M | 21.8 M | 16.6 M | 15.2 M | 16 M | 8.58 M | 8.58 M | 8.58 M | 8.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency